$3.80

0.1 (2.56%)

Want access to our research and new buy ideas?

Take a free 15 day trial - no credit card required.

Start your free trial now

MVP General Information

Medical Developments International Limited
MVP
http://www.medicaldev.com
Pharmaceuticals
249
65

MVP Current Share Price+

Current Price $3.800
Open $3.900
High $3.900
Low $3.800
Last Close $3.900
Volume 46538
Price Movement $0.10 ( 2.56% )
  • +Security prices are delayed by at least 20 minutes and are indicative only.

MVP Company Overview

Business Description

Medical Developments International Limited (MVP) is an Australia-based healthcare company. MVP offers a range of open and closed circuit anaesthetic machines to the veterinary market, which are known as Komesaroff anaesthetic machines. With an industry leading range of products in the areas of pain management, asthma and resuscitation, plus veterinary equipment. Company has established a network of manufactures and distributors to ensure both quality assurance and supply chain solutions are maintained for servicing and delivering to both the local and international sectors.

MVP Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2020 F 0.00 5.90 180.10% 64.30 4.00 1.10% 0.0%
2019 F 0.00 2.10 414.60% 180.10 4.00 1.10% 0.0%
2018 A 0.24 0.40 -86.80% 1,542.00 4.00 0.60% 100.0%

MVP Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2018 A 2019 F 2020 F 2018 A 2019 F 2020 F 2018 A 2019 F 2020 F
Medical Developments International (MVP) $255M -0.8677 4.1463 1.8009 951.2195 184.8341 65.9898 1.03% 1.03% 1.03%
Mayne Pharma Group (MYX) $1,504M -0.5645 0.7561 0.2877 33.1010 18.8492 14.6379 0.00% 0.00% 0.00%
Starpharma (SPL) $553M 0.0000 0.0000 1.0848 0.0000 43.5673 20.8976 0.00% 0.00% 0.00%

MVP Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 3.00 321.20 10.69 1.15
Market 0.72 14.10 1.24 0.95
Sector 0.57 23.70 3.05 1.70

MVP Directors

Name Position Start Date
Mr David Williams Non-Executive Chairman, Non-Executive Director 16 Sep 2003
Mr Allan D McCallum Non-Executive Director 27 Nov 2003
Mr Philip (Phil) John Powell Non-Executive Director 17 Dec 2014
Mr Harry Frank Oxer Non-Executive Director 28 Dec 2006
Mr Robert (Max) Maxwell Johnston Non-Executive Director 5 Nov 2012
Mr Leon Hoare Non-Executive Director 27 Sep 2013

MVP Management

Name Position
John Stewart Sharman Chief Executive Officer
Mark Edwards Group Financial Controller,Company Secretary

MVP Substantial Shareholders

Holding Name
9,459,584 (14.93%) Williams, David John

MVP Calendar of Events

Date Event
20 September 2019 Report (Annual)
16 August 2019 Report (Prelim)
15 February 2019 Report (Interim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.